Skip to content

Inosine

DERMATOLOGICALS

Also known as: 9-beta-D-Ribofuranosylhypoxanthine, hypoxanthine ribonucleoside, hypoxanthine riboside, hypoxanthosine, oxiamin, ribonosine

FDA approvedATC D06BB05ATC G01AX02ATC S01XA10

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Inosine is a drug catalogued in DrugCentral.

  • ATC code: D06BB05 (Antivirals).
  • Molecular formula: C10H12N4O5; molecular weight 268.23 g/mol.

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
D06BB05DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Antivirals
G01AX02GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Other antiinfectives and antiseptics
S01XA10SENSORY ORGANS › OPHTHALMOLOGICALS › OTHER OPHTHALMOLOGICALS › Other ophthalmologicals

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Inosine is on its molecule page.

Molecular formulaC10H12N4O5
Molecular weight268.23 g/mol
CAS number58-63-9
InChIKeyUGQMRVRMYYASKQ-KQYNXXCUSA-N
PubChem CID135398641
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Inosine?

Inosine has the molecular formula C10H12N4O5 and a molecular weight of 268.23 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications0
FormulaC10H12N4O5
DrugCentral ID3301
Interactive profile